Drug Use Clinical Trial
Official title:
A GIS Mapping Exercise to Assess the Need for Injecting Equipment Provision (IEP) Services and Overdose Prevention Activities in Tayside.
The aim of this study is to review the current provision of IEP services provided across Tayside and consider to what extent they are contributing to keeping this vulnerable population safe. The study will look at the coverage provided by the current service and map this against the known harms e.g. drugs litter finds, incidences of non-fatal overdoses and drug related deaths. This mapping process will then allow recommendations to be made in a strategic way to advise future service delivery plans to ensure that services are delivered that are reachable to the communities that need these valuable services.
People who inject drugs (PWIDs) do so at significant risk to themselves due to transmission
of blood borne viruses (BBV), injecting injuries, bacterial infections and drug related
deaths.
NHS Tayside has a responsibility for improving the health of the population. PWIDs represent
a particularly vulnerable group who experience significant health inequalities as well as
stigmatisation and discriminatory attitudes.
Injecting Equipment Provision (IEP) services contribute to a reduction in BBV transmission
through the provision of free sterile equipment for each injection. IEP services also provide
advice on good injecting technique to avoid injecting injuries and bacterial infections.
Crucially they can also provide "take home naloxone". Intramuscular injection of naloxone is
a first aid emergency response for potentially fatal opiate overdoses and provides more time
for emergency services to attend. Supplies of "take home naloxone" are made, along with
training on overdose awareness, to those individuals at risk of opioid overdose in order to
reduce the risk of fatality.
IEP services contribute to a reduction in drug related deaths by engaging with those thought
to be most at risk, either through poly substance use or those who are not engaged with other
services
The aim of this study is to review the current provision of IEP services provided across
Tayside and consider to what extent they are contributing to keeping this vulnerable
population safe. The study will look at the coverage provided by the current service and map
this against the known harms e.g. drugs litter finds, incidences of non-fatal overdoses and
drug related deaths. This mapping process will then allow recommendations to be made in a
strategic way to advise future service delivery plans to ensure that services are delivered
that are reachable to the communities that need these valuable services.
The protocol has been peer reviewed by the expert working group established to review the
current provision of IEP and harm reduction and overdose awareness services across Tayside
Individual consent from patients will not be sought. The data provided by the databases will
be retrospective 4 digit postcode data and will not include patient identifiable information.
The data obtained will not be used in any way which may influence the care of the patient.
Data collection methods will not identify individual patients.
Researchers will be accessing information from databases which they have access to as part of
their routine work. Information will remain anonymous and patient confidentiality will be
upheld.
Separate consents will be sought to allow council colleagues to provide information on drug
litter finds.
Anonymous 4 digit postcode data will be transferred onto Geographic Information System (GIS)
maps to demonstrate coverage of services mapped against known harms (non-fatal overdoses,
drug related deaths and drug litter finds). GIS maps do not identify individual postcodes.
The GIS maps will be used to identify gaps in the provision of services and provide an
evidence base behind recommendations to improve service provision.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05468879 -
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
|
N/A | |
Not yet recruiting |
NCT06395129 -
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
|
||
Completed |
NCT02293057 -
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
|
N/A | |
Completed |
NCT01941108 -
Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care
|
N/A | |
Completed |
NCT01380613 -
Neighborhoods, Networks, Depression, and HIV Risk
|
Phase 2 | |
Withdrawn |
NCT00914719 -
Alcohol Use and Sexual Risk: An Intervention
|
N/A | |
Recruiting |
NCT03671629 -
Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly
|
N/A | |
Completed |
NCT03290391 -
Linking Infectious and Narcology Care-Part II
|
Phase 4 | |
Completed |
NCT04008927 -
A Community-based Intervention Among Active Drug Users in Montpellier
|
N/A | |
Completed |
NCT03627546 -
HCV Seek, Test and Rapid Treatment for Young PWID
|
N/A | |
Not yet recruiting |
NCT03967262 -
Secondary Prevention and Recidivism Reduction in Trauma Patients
|
N/A | |
Completed |
NCT03079856 -
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
|
N/A | |
Completed |
NCT03855410 -
Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention
|
N/A | |
Terminated |
NCT02457949 -
The Impact of Alternative Social Assistance Disbursement on Drug-related Harm
|
N/A | |
Completed |
NCT06238154 -
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
|
Phase 4 | |
Terminated |
NCT04436055 -
Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
|
||
Recruiting |
NCT04717856 -
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
|
N/A | |
Completed |
NCT00249496 -
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
|
N/A | |
Recruiting |
NCT05597865 -
Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents
|
N/A | |
Completed |
NCT05553054 -
Drug Wastage : Observational Study in Intensive Care Units in France
|